יום חמישי, כ״א אלול תשפ״וThursday, September 3, 2026
Follow Us
If Dr. Lichtenstein’s research pans out, patients with Alzheimer’s and Parkinson’s might also benefit.
By Jewish News Syndicate (JNS)
Stem cell treatment developed by Israeli company BrainStorm Cell Therapeutics has been designated by the U.S. Food and Drug Administration (FDA) as a "fast-track" treatment of amyotrophic lateral sclerosis (ALS).
September 4, 2026 
